Apr 25 2011
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced a new three-year agreement with Amerinet, Inc., a national healthcare group purchasing organization. Amerinet selected Arrow Peripherally Inserted Central Catheters (PICCs) as part of a multi source agreement. The new agreement begins May 1, 2011 and extends through April 30, 2014.
The Arrow PICC product line includes the recently introduced Arrow EVOLUTION™ PICC with Chlorag+ard™ antimicrobial technology, the first Chlorhexidine-treated peripherally inserted central catheter with both intraluminal and extraluminal protection. Chlorag+ard technology provides broad spectrum antimicrobial protection against bacterial and fungal colonization.
The broad range of Arrow vascular access products includes central venous access catheters, peripherally inserted central catheters, multi access catheters and acute hemodialysis catheters many of which are now available in ErgoPack Maximal Barrier Precautions Trays, a system designed to support compliance with best practice and guidelines for catheter insertion.
Teleflex also recently expanded its vascular access product offerings with the acquisition of the VasoNova VPS, vascular positioning system, a central venous catheter tip navigation system.
Source: Amerinet